The Role of Sclerostin in Rheumatic Diseases: A Review

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Oct 14

PMID 37834893

Authors

Lukasz Jaskiewicz

Grzegorz Chmielewski

Jakub Kuna

Tomasz Stompor

Magdalena Krajewska-Wlodarczyk

Affiliations

Soon will be listed here.

Abstract

Systemic connective tissue disorders constitute a heterogenous group of autoimmune diseases with the potential to affect a range of organs. Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune inflammatory disease affecting the joints. Systemic lupus erythematosus (SLE) may manifest with multiple system involvement as a result of inflammatory response to autoantibodies. Spondyloarthropathies (SpAs) such as ankylosing spondylitis (AS) or psoriatic arthritis (PsA) are diseases characterised by the inflammation of spinal joints, paraspinal tissues, peripheral joints and enthesitis as well as inflammatory changes in many other systems and organs. Physiologically, sclerostin helps to maintain balance in bone tissue metabolism through the Wnt/β-catenin pathway, which represents a major intracellular signalling pathway. This review article aims to present the current knowledge on the role of sclerostin in the Wnt/β-catenin pathway and its correlation with clinical data from RA, SLE, AS and PsA patients.

Citing Articles

A guideline on biomarkers in the diagnosis and evaluation in axial spondyloarthritis.

Liu D, Xie Y, Tu L, Wen X, Lv Q, Liu B Front Immunol. 2024; 15:1394148.

PMID: 39539543 PMC: 11557325. DOI: 10.3389/fimmu.2024.1394148.

Elevated Circulating Sclerostin Levels in Frail Older Adults: Implications beyond Bone Health.

Baek J, Ahn S, Jang I, Jung H, Ji E, Park S Endocrinol Metab (Seoul). 2024; 40(1):73-81.

PMID: 39443828 PMC: 11898323. DOI: 10.3803/EnM.2024.2100.

Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor Therapy.

Szeremeta A, Jura-Poltorak A, Zon-Giebel A, Olczyk K, Komosinska-Vassev K Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931334 PMC: 11206420. DOI: 10.3390/ph17060666.

Association Between Sleep Apnea Syndrome and Osteoarthritis: Insights from Bidirectional Mendelian Randomization and Bioinformatics Analysis.

Weng L, Luo X, Luo Y, Zhang Q, Yao K, Tan J Nat Sci Sleep. 2024; 16:473-487.

PMID: 38737460 PMC: 11088414. DOI: 10.2147/NSS.S461010.

References

Wehmeyer C, Frank S, Beckmann D, Bottcher M, Cromme C, Konig U . Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Sci Transl Med. 2016; 8(330):330ra35. DOI: 10.1126/scitranslmed.aac4351. View

Wu C, Yang H, Lai J . Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis. Int J Mol Sci. 2020; 21(11). PMC: 7312469. DOI: 10.3390/ijms21114015. View

Chen L, Wei X, Evans B, Jiang W, Aeschlimann D . IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol. 2008; 38(10):2845-54. DOI: 10.1002/eji.200838192. View

Terpos E, Fragiadaki K, Konsta M, Bratengeier C, Papatheodorou A, Sfikakis P . Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. Clin Exp Rheumatol. 2011; 29(6):921-5. View

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

Carter S, Braem K, Lories R . The role of bone morphogenetic proteins in ankylosing spondylitis. Ther Adv Musculoskelet Dis. 2012; 4(4):293-9. PMC: 3403253. DOI: 10.1177/1759720X12444175. View

Korkosz M, Gasowski J, Leszczynski P, Pawlak-Bus K, Jeka S, Kucharska E . High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage. BMC Musculoskelet Disord. 2013; 14:99. PMC: 3639156. DOI: 10.1186/1471-2474-14-99. View

Swierkot J, Gruszecka K, Matuszewska A, Wiland P . Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. Arch Immunol Ther Exp (Warsz). 2015; 63(5):397-404. PMC: 4572055. DOI: 10.1007/s00005-015-0338-x. View

Bagheri-Hosseinabadi Z, Mirzaei M, Esmaeili O, Asadi F, Ahmadinia H, Shamsoddini B . Implications of Peptidyl Arginine Deiminase 4 gene transcription and polymorphisms in susceptibility to rheumatoid arthritis in an Iranian population. BMC Med Genomics. 2023; 16(1):104. PMC: 10186752. DOI: 10.1186/s12920-023-01532-9. View

10.

Itasaki N, Jones C, Mercurio S, Rowe A, Domingos P, Smith J . Wise, a context-dependent activator and inhibitor of Wnt signalling. Development. 2003; 130(18):4295-305. DOI: 10.1242/dev.00674. View

11.

Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico R . Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010; 95(5):2248-53. DOI: 10.1210/jc.2010-0067. View

12.

Sakellariou G, Anastasilakis A, Bisbinas I, Oikonomou D, Gerou S, Polyzos S . Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation. Rheumatology (Oxford). 2014; 54(5):908-14. DOI: 10.1093/rheumatology/keu425. View

13.

Solmaz D, Uslu S, Kozaci D, Karaca N, Bulbul H, Tarhan E . Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway. Int J Rheum Dis. 2017; 21(2):502-509. DOI: 10.1111/1756-185X.13186. View

14.

Itoh K, Antipova A, Ratcliffe M, Sokol S . Interaction of dishevelled and Xenopus axin-related protein is required for wnt signal transduction. Mol Cell Biol. 2000; 20(6):2228-38. PMC: 110839. DOI: 10.1128/MCB.20.6.2228-2238.2000. View

15.

Perrotta F, Ceccarelli F, Barbati C, Colasanti T, De Socio A, Scriffignano S . Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study. J Immunol Res. 2018; 2018:9101964. PMC: 5954944. DOI: 10.1155/2018/9101964. View

16.

Sarkar S, Cooney L, Fox D . The role of T helper type 17 cells in inflammatory arthritis. Clin Exp Immunol. 2009; 159(3):225-37. PMC: 2819489. DOI: 10.1111/j.1365-2249.2009.04016.x. View

17.

Marahleh A, Kitaura H, Ohori F, Kishikawa A, Ogawa S, Shen W . TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. Front Immunol. 2020; 10:2925. PMC: 6923682. DOI: 10.3389/fimmu.2019.02925. View

18.

Mulhearn B, Tansley S, McHugh N . Autoantibodies in connective tissue disease. Best Pract Res Clin Rheumatol. 2019; 34(1):101462. DOI: 10.1016/j.berh.2019.101462. View

19.

Dorner T, Furie R . Novel paradigms in systemic lupus erythematosus. Lancet. 2019; 393(10188):2344-2358. DOI: 10.1016/S0140-6736(19)30546-X. View

20.

Tveita A, Rekvig O . Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development. Arthritis Rheum. 2011; 63(2):513-22. DOI: 10.1002/art.30116. View